Amphotericin B-impregnated bone cement to treat refractory coccidioidal osteomyelitis

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Use of amphotericin B-impregnated bone cement in combination with systemic antifungals for the treatment of coccidioidal osteomyelitis offers the potential for sustained local concentrations of drug at the site of the infection. Amphotericin B levels in bone of up to 5.1 μg/g have been demonstrated 4 months after placement of bone cement.

Original languageEnglish (US)
Pages (from-to)6341-6343
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume57
Issue number12
DOIs
StatePublished - Dec 2013

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Amphotericin B-impregnated bone cement to treat refractory coccidioidal osteomyelitis'. Together they form a unique fingerprint.

  • Cite this